External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ADA 2026

-
Coming soon
05:30 PM
Duration 60mins New Orleans, USA
Influence of Baseline Diabetes Severity on Clinical and Economic Outcomes in Faricimab▼-Treated Diabetic Macular Edema: Linked Analysis of Administrative Claims and IRIS Registry Data
Blake A. Cooper, Stella Ko, Xiaowu Sun, Jessica Clubb, Ayesha Ahmed, Bryan Moore, Laura Lupton, Dingwei Dai, Yi Liu, Yimin Wu, Nicole Gidaya Bonine
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins New Orleans, USA
Reexamining the Diabetic Eye Disease Care Continuum - a National Health Plan Perspective
Aryan Ayati, Frank Brodie, Stella Ko, Ruth Wangia Dixon, Kayla Crocker, Hiangkiat Tan, Ayesha Ahmed, Alexandra Warter, Keith Knuth, Judy Kim, David Tabano
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins New Orleans, USA
Machine Learning-Driven Discovery of Behavioral Drivers and Barriers to Glycemic Control
Ezgi Cinar, Delphine Theodorou, Michael Mitter
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:30 PM
Duration 60mins New Orleans, USA
CT-388, a cAMP Dual Signal-biased GLP-1/GIP Receptor Agonist, Achieves Clinically Meaningful Weight Reduction in People With Overweight/Obesity: a 48-weeks Phase 2 Study
Ildiko Lingvay, Alexandra Steinberg, Carel Le-Roux, Ania M. Jastreboff, Stephan Sharp, Sureka Bollepalli, Kenneth Kim, Dan Lender, Harold Bays, Giuseppe Palermo, Esther Shearer-Kang, Jeffrey R. Willis, Manu V. Chakravarthy
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar